Introduced in the SenateSenate Bill

Shandra Eisenga Human Cell and Tissue Product Safety Act

Summary · Congressional Research Service (nonpartisan)

This bill requires the Department of Health and Human Services (HHS) to educate the public and health care providers about the benefits and risks of transplants that use human cell or tissue products, including the risk of infections. HHS must develop the educational campaign after taking into consideration information about products that carry the highest risk of transmitting infections to transplant recipients. HHS may award grants to other entities to conduct public awareness initiatives and media campaigns about the risk of infections. The bill also establishes specific civil penalties for violations of laws regarding the spread of communicable diseases and regulations regarding procedures for human cell or tissue products.

Introduced Feb 5, 2024GovTrack

Ask AI About This Bill

Get plain-language answers with direct quotes from the bill text.

to ask questions about this bill.

Your Representatives

Enter your address to see how your representatives voted on this bill.

Your address is only used to find your district and is never saved. See how it works

Votes

Public Opinion

No votes yet — be the first to weigh in.

to cast your vote

Your voice matters — let representatives know where you stand.

Comments

No comments yet. to be the first to weigh in.